New salicylamide and sulfonamide derivatives of quinoxaline 1,4-di-N-oxide with antileishmanial and antimalarial activities.
Carlos Barea, Adriana Pabón, Denis Castillo, Mirko Zimic, Miguel Quiliano, Silvia Galiano, Silvia Pérez-Silanes, Antonio Monge, Eric Deharo, Ignacio Aldana
Index: Bioorg. Med. Chem. Lett. 21(15) , 4498-502, (2011)
Full Text: HTML
Abstract
Continuing with our efforts to identify new active compounds against malaria and leishmaniasis, 14 new 3-amino-1,4-di-N-oxide quinoxaline-2-carbonitrile derivatives were synthesized and evaluated for their in vitro antimalarial and antileishmanial activity against Plasmodium falciparum Colombian FCR-3 strain and Leishmania amazonensis strain MHOM/BR/76/LTB-012A. Further computational studies were carried out in order to analyze graphic SAR and ADME properties. The results obtained indicate that compounds with one halogenous group substituted in position 6 and 7 provide an efficient approach for further development of antimalarial and antileishmanial agents. In addition, interesting ADME properties were found.Copyright © 2011 Elsevier Ltd. All rights reserved.
Related Compounds
Related Articles:
2012-02-01
[Br. J. Pharmacol. 165(4b) , 1058-67, (2012)]
[J. Org. Chem. 58 , 3543, (1993)]
Aziridine ring-containing chiral ligands as highly efficient catalysts in asymmetric synthesis. Rachwalski M, et al.
[Tetrahedron Asymmetry 24(7) , 421-25, (2013)]